News from NORD

Certification in Rare Neuroimmunologic Disorders


 

The Consortium of Multiple Sclerosis Centers (CMSC) has announced that the next Certification Examination in Rare Neuroimmunologic Disorders will take place in January 2017. The application deadline is December 1, 2016. Certification in Rare Neuroimmunologic Disorders (CRND) is intended to validate quality and consistent care to those living with rare neuroimmunologic disorders of the central nervous system.

These rare disorders include transverse myelitis, neuromyelitis optica spectrum disorder, optic neuritis, acute disseminated encephalomyelitis, and anti-NMDA receptor encephalitis. All licensed health professionals with a recommended one year of experience in providing services for patients with rare neuroimmunologic disorders are eligible to take the examination.

Those who successfully pass the certification exam will be eligible to use the registered designation CRND after their names and will receive certificates from CMSC.

Additional information about this certification program and examination may be found on the following page on the CMSC website: http://www.mscare.org/page/about_crnd

Recommended Reading

Postexposure Prophylaxis May Prevent Ebola Disease Development
Clinician Reviews
Pediatric Cardiomyopathy Is the #1 Cause of Sudden Cardiac Arrest in Children Under Age 18
Clinician Reviews
Updates in Pediatrics
Clinician Reviews
Bone disease in patients with kidney disease: A tricky interplay
Clinician Reviews
NORD Rare Diseases and Orphan Products Summit to Feature Speakers from FDA, NIH, and ACMG
Clinician Reviews
NORD Issues Statement as US Senate Postpones Vote on Cures Legislation
Clinician Reviews
NORD Announces 2016 Grant Opportunities
Clinician Reviews
Register Now for the NORD Summit!
Clinician Reviews
Running for Rare Team Raises Funds for NORD Program for Undiagnosed Patients
Clinician Reviews
Recurrent right upper quadrant abdominal pain
Clinician Reviews